(Q39000791)

8 September 2017

title

Efficient bioactive delivery of aerosolized drugs to human pulmonary epithelial cells cultured in air-liquid interface conditions (English)

1 reference

8 September 2017

8

Oliver Eickelberg

1 reference

8 September 2017

Anke-Gabriele Lenz

1

1 reference

8 September 2017

Tobias Stoeger

2

1 reference

8 September 2017

Daniele Cei

3

1 reference

8 September 2017

Martina Schmidmeir

4

1 reference

8 September 2017

Nora Semren

5

1 reference

8 September 2017

Gerald Burgstaller

6

1 reference

8 September 2017

Bernd Lentner

7

1 reference

8 September 2017

Silke Meiners

9

1 reference

8 September 2017

Otmar Schmid

10

1 reference

8 September 2017

publication date

1 October 2014

1 reference

American Journal of Respiratory Cell and Molecular Biology

8 September 2017

published in

1 reference

8 September 2017

volume

51

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

526-535

1 reference

Inhaling medicines: delivering drugs to the body through the lungs

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Airway delivery of peptides and proteins using nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Cell culture models of the respiratory tract relevant to pulmonary drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

A three-dimensional cellular model of the human respiratory tract to study the interaction with particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Pulmonary surfactant is indispensable in order to simulate the in vivo situation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

A novel cell compatible impingement system to study in vitro drug absorption from dry powder aerosol formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Cellular response to the deposition of diesel exhaust particle aerosols onto human lung cells grown at the air-liquid interface by inertial impaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Exposure of human lung cells to native diesel motor exhaust--development of an optimized in vitro test strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Simulated lung transfection by nebulization of liposome cDNA complexes using a cascade impactor seeded with 2-CFSME0-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Accessibility of the coxsackievirus and adenovirus receptor and its importance in adenovirus gene transduction efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

A high-throughput screening method based on stably transformed human cells was used to determine the immunotoxic effects of fluoranthene and other PAHs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Human nasal and tracheo-bronchial respiratory epithelial cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Airway surfactant, a primary defense barrier: mechanical and immunological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Airway mucus function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Proteasome inhibition: a new anti-inflammatory strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Proteasome inhibitors: poisons and remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Proteasome inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung—A dialog between aerosol science and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

Dendritic Cells and Macrophages Form a Transepithelial Network against Foreign Particulate Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2013-0479OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2013-0479OC

1 reference

8 September 2017

1 reference